Has Erin McLaughlin, PA received payments from drug or device companies?

Yes. Drug and device makers reported $3,479 in general payments to Erin McLaughlin, PA across 100 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Erin McLaughlin, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Erin McLaughlin, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Erin McLaughlin, PA

Medical · Knoxville, TNNPI 1174244735

Payments from drug & device makers

$3,479in general payments, 2019–2025

Across 100 payments — averaging $34.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pacira Pharmaceuticals Incorporated$1K
Amgen$264
Convatec Inc.$252
Johnson & Johnson$231
Incyte Corporation$206
Cerapedics Inc.$119
plus $1K from 37 others

What the payments were for

Travel & lodging$85124%
Food & beverage$2,50072%
Education$1284%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pacira Pharmaceuticals Incorporated	6	$1,029
Amgen	10	$264
Convatec Inc.	5	$252
Johnson & Johnson(2 entities)	9	$231
Incyte Corporation	6	$206
Cerapedics Inc.	3	$119
Merck	4	$110
Vertex	3	$78
Genentech USA, Inc.	3	$76
GSK	3	$68
Bayer	3	$66
Beone Medicines USA, Inc.	3	$62
Astellas Pharma US Inc	3	$61
Bioventus LLC	3	$58
Regeneron Healthcare Solutions, Inc.	2	$57
AstraZeneca	2	$52
AbbVie	1	$50
Novocure Inc.	2	$45
Puma Biotechnology, Inc.	2	$44
Medtronic	2	$41
Lilly USA, LLC	2	$37
Si-bone, Inc.	1	$28
Rigel Pharmaceuticals, Inc.	1	$27
Caris MPI, Inc.	1	$26
Deciphera Pharmaceuticals Inc.	1	$25
Daiichi Sankyo Inc.	1	$25
Bristol Myers Squibb	1	$23
Fidia Pharma USA Inc.	1	$22
Smoky Mountain Surgical LLC	1	$22
DJO, LLC	1	$22
AVEO Pharmaceuticals, Inc.	1	$22
Takeda Pharmaceuticals U.S.A., Inc.	1	$22
Iovance Biotherapeutics, Inc.	1	$21
Pharmaessentia USA Corporation	1	$21
Nevro Corp.	1	$20
Organogenesis Inc.	1	$20
EMD Serono, Inc.	1	$20
E.r. Squibb & Sons, L.L.C.	1	$20
Pharmacosmos Therapeutics Inc.	1	$19
Sanara Medtech Inc.	2	$17
Arteriocyte Medical Systems, Inc.	1	$17
Geron Corporation	1	$17
BREG, Inc	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,479 in reported general payments places this provider in the 80th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee →

Medicare billing

Part B allowed, 2024

$50,205

Medicare patients

153

Services billed

1,622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	432	$11,037
Lidocaine-PrilocaineLidocaine/Prilocaine	46	$9,973
Lidocaine	56	$4,268
Gabapentin	174	$1,750
Naloxone Hcl	21	$1,359
Tizanidine Hcl	184	$1,349
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	57	$884
Pregabalin	60	$852
Celecoxib	46	$771
Ondansetron OdtOndansetron	36	$722
Diclofenac Sodium	25	$651
Methocarbamol	27	$648
Cephalexin	63	$484
Cyclobenzaprine Hcl	58	$265
Meloxicam	94	$231

Paid to pharmacies, not to this prescriber.

Other medical in Knoxville

Stephanie HowardKnoxville$18K
Janet BreedingKnoxville$15K
Paul MabenKnoxville$13K
Tara PiankoKnoxville$8K
Jaan KellyKnoxville$6K
Tonya JonesKnoxville$5K
Maria WoodChattanooga$130K
Alyssa JamesonFranklin$65K
Melissa LambertHendersonville$47K
Evan HatfillNashville$18K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →